These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14235737)

  • 1. [PAPER CHROMATOGRAPHIC DEMONSTRATION OF THE ANTICOAGULANTS 3-(1-PHENYLPROPYL)-4-HYDROXYCOUMARIN (FALITHROM) AND THE ETHYL ESTER OF DIHYDROXYCOUMARINYLACETIC ACID (PELENTAN)].
    FROST E; SEIDLEIN HJ
    Pharm Prax; 1964; 204():28-33. PubMed ID: 14235737
    [No Abstract]   [Full Text] [Related]  

  • 2. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 3. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
    BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
    Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
    [No Abstract]   [Full Text] [Related]  

  • 4. New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
    GOLD H; LILLEY GW
    J Am Med Assoc; 1959 Jul; 170(11):1303-6. PubMed ID: 13664522
    [No Abstract]   [Full Text] [Related]  

  • 5. SYNTHESES OF SOME 4-HYDROXYCOUMARINS AND THEIR CONDENSATION PRODUCTS WITH ALDEHYDES AND CARBOXYLIC ACIDS. THE ANTICOAGULANT ACTIVITY OF SOME 4-HYDROXYCOUMARIN DERIVATIVES.
    DEZELIC M; TRKOVNIK M
    J Med Chem; 1964 May; 7():284-8. PubMed ID: 14204961
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECT OF ALKYL SUBSTITUTION IN DRUGS. 8. CHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SUBSTITUTED 3-ARYL-4-HYDROXYCOUMARINS.
    VAN ZANTEN ; NAUTA WT
    Arzneimittelforschung; 1964 Jan; 14():29-34. PubMed ID: 14223687
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of 3-(1-phenylpropyl)-4-hydroxycoumarin (marcumar) on the functional, morphological and histochemical characteristics of blood platelets and megakaryocytes; experimental research].
    SALVI F; RICCI M
    Haematologica; 1955; 39(6):425-40. PubMed ID: 13262650
    [No Abstract]   [Full Text] [Related]  

  • 9. Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.
    BURKE GE; WRIGHT IS
    Circulation; 1951 Feb; 3(2):164-70. PubMed ID: 14812644
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on anticoagulants; pelentan metabolites in human and rabbit urine].
    PROCHAZKA Z
    Cesk Farm; 1952; 1(11-12):637-46. PubMed ID: 13033003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
    KNOBEL P
    Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of 3-(1'-phenylpropyl)-4-hydroxycoumarin by means of high-performance liquid chromatography (HPLC) (author's transl)].
    Kinawi A
    Arzneimittelforschung; 1977 Feb; 27(2):360-3. PubMed ID: 577154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical characteristics of the main product of anticoagulant pelentan in human urine].
    FUCIK K; HAIS IM; KAKAC B; KNOBLOCH E; PROCHAZKA Z
    Cesk Fysiol; 1955 Jul; 4(3):342-8. PubMed ID: 13276975
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
    VAN WIEN A; VEROFT R
    Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical characterization of the main metabolic product of the anticoagulant drug, pelentan, in human urine.
    FUCIK K; HAIS IM; KAKAC B; KNOBLOCH E; PROCHAZKA Z
    Chekh Fiziol; 1955; 4(3):308-15. PubMed ID: 13330094
    [No Abstract]   [Full Text] [Related]  

  • 18. [CHANGES IN THE HAMOLSKY TEST IN RATS AFTER ADMINISTRATION OF ANTICOAGULANT SUBSTANCES (HEPARIN AND 4-HYDROXYCOUMARIN)].
    CABASSA N; SCIASCIA R
    Radiobiol Radioter Fis Med; 1964; 19():3-9. PubMed ID: 14169297
    [No Abstract]   [Full Text] [Related]  

  • 19. [CONTRIBUTIONS TO INFORMATION ON COUMARINS. 3. THE PREPARATION OF SOME 3-MONOACYLAMINO-4-HYDROXYCOUMARINS AND N-(4-HYDROXY-3-COUMARINYL)-UREAS].
    REPPEL L; SCHMOLLACK W
    Arch Pharm Ber Dtsch Pharm Ges; 1964 Jan; 297():45-50. PubMed ID: 14217211
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with 3-(1-phenylpropyl)-4-hydroxycoumarin.
    FAIRBAIRN JF; ESTES JE
    Proc Staff Meet Mayo Clin; 1957 Jun; 32(13):342-9. PubMed ID: 13441770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.